Pfizer: FDA approves Covid vaccine update

(CercleFinance.com) - Pfizer and BioNTech announced that the FDA has approved the use of their COVID-19 vaccine adapted to the Omicron KP.
2 strain for people aged 12 and over, with emergency use authorization for children aged 6 months to 11 years.

This vaccine, intended for the 2024-2025 season, will be available as a single dose for most people aged 5 and over.

Approval is based on clinical evidence showing an improved response against Omicron variants.

The vaccine will soon be available in pharmacies and clinics in the US.


Copyright (c) 2024 CercleFinance.com. All rights reserved.